Aminopeptidase

Aminopeptidase Aeromonas Recombinant
Shipped with Ice Packs
In Stock

Description

Definition and Core Function

Aminopeptidases are exoproteases that sequentially hydrolyze N-terminal residues from polypeptides. They are classified into two main categories:

  • Metalloaminopeptidases: Zinc- or manganese-dependent enzymes with a conserved HEXXH motif for metal coordination .

  • Cysteine aminopeptidases: Utilize a catalytic cysteine residue for substrate cleavage .

These enzymes exhibit broad substrate specificity, enabling them to process diverse peptides and proteins in intracellular and extracellular environments .

Domain Architecture

  • Aminopeptidase N (APN): A seahorse-shaped, type II transmembrane protein with four domains (head, side, body, tail). Its active site resides in a spacious cavity, facilitating substrate accessibility .

  • Dimerization: APN forms head-to-head dimers, stabilizing its structure for multifunctional roles .

  • Catalytic Mechanism: The zinc-binding site coordinates hydrolysis via a HEXXH motif, while conformational changes between "open" (inactive) and "closed" (active) states regulate activity .

Protein Metabolism

  • Digestion: APN in intestinal brush borders degrades dietary peptides for nutrient absorption .

  • Biofilm Maintenance: Pseudomonas aeruginosa aminopeptidase (PaAP) recycles nutrients in biofilms, aiding bacterial persistence .

Genome Stability

  • Aminopeptidase-P (APP1): Prevents replication-associated DNA damage by resolving genotoxic stress during DNA unwinding .

Disease Pathways

  • Cancer: APN (CD13) is overexpressed in prostate cancer; cyclic peptide inhibitors (e.g., cyc-LHSPW, Kᵢ = 24.7 μM) suppress tumor growth .

  • Malaria: Plasmodium M1/M17 aminopeptidases are drug targets, with Co²⁺ modulating their activity .

Catalytic Efficiency

  • PaPepA processes substrates with a k<sub>cat</sub>/K<sub>M</sub> range of 1.2–15.6 mM⁻¹s⁻¹, preferring Leu, Met, Phe, and Arg residues .

  • Calcium Regulation: Human aminopeptidase A (APA) shows enhanced activity toward acidic N-terminal residues (e.g., angiotensin II) in the presence of Ca²⁺ .

Table 2: Substrate Selectivity of PaPepA7

Substrate (aa-pNA)k<sub>cat</sub> (s⁻¹)K<sub>M</sub> (mM)k<sub>cat</sub>/K<sub>M</sub> (mM⁻¹s⁻¹)
Leucine15.6 ± 0.81.0 ± 0.115.6
Arginine10.2 ± 0.51.2 ± 0.28.5
Proline0.2 ± 0.022.5 ± 0.30.08

Inhibitor Design

  • Anti-Biofilm Agents: Cyclic peptides mimicking PaAP’s C-terminal propeptide disrupt biofilm formation in P. aeruginosa .

  • Anticancer Therapeutics: APN-targeting peptides (e.g., cyc-LHSPW) reduce prostate cancer cell viability by 80% in vivo .

Diagnostic Markers

  • Elevated serum APN correlates with liver damage and leukemia prognosis .

Evolutionary and Functional Diversity

  • Bacterial vs. Mammalian APNs: While bacterial APNs (e.g., Mesorhizobium MesoAmp) thrive in extreme environments, mammalian APNs regulate peptide hormones like angiotensin .

  • Viral Receptors: APN serves as an entry receptor for coronaviruses, independent of its enzymatic activity .

Research Frontiers

  • Conformational Dynamics: Structural studies using cryo-EM aim to map APN’s open/closed transitions during catalysis .

  • Gene Editing: CRISPR-Cas9 screens identify APN isoforms linked to chemotherapy resistance .

Product Specs

Description
The 29 kDa Aeromonas Aminopeptidase, produced via genetic engineering, is suitable for physical and structural investigations, sequence and amino-terminal determinations. This exopeptidase, which recognizes a specific stop sign at -X-Pro and requires a free α-amino group in the L-configuration, is suitable for removing the redundant N-terminal methionine often added to engineered recombinant proteins.
Physical Appearance
Sterile filtered liquid.
Formulation
Buffered solution containing 10mM Tris-HCl, 100mM NaCl, and 5µM ZnSO4, pH 8.0.
Stability
Stable for two years when stored at -20°C, and for two weeks at 4°C.
Purity
Greater than 95.0% purity as determined by SEC-HPLC.
Biological Activity
Recombinant Aeromonas Aminopeptidase exhibits an activity of 108 Units/mg protein.
Unit Definition
One unit of aminopeptidase activity is defined as the amount of enzyme that releases 1 µmole p-nitroaniline per minute at 25°C.
Synonyms
Bacterial leucyl aminopeptidase, EC 3.4.11.10.
Source
Aeromonas Proteolytica.

Q&A

What are aminopeptidases and how do they function biochemically?

Aminopeptidases are hydrolytic enzymes that catalyze the sequential removal of amino acids from the N-terminus of peptides and proteins. They function through a highly specific cleavage mechanism, removing one amino acid at a time from protein substrates. Unlike carboxypeptidases which target the C-terminus, aminopeptidases specifically recognize and cleave at the N-terminal end of proteins .

These enzymes are classified based on multiple criteria including the number of amino acids they cleave (single aminopeptidases, dipeptidyl peptidases, or tripeptidyl peptidases), the specific residues they remove (alanyl, arginyl, aspartyl, etc.), and other factors such as location, pH requirements, metal ion content, and inhibition susceptibility . Most aminopeptidases belong to the M1 family of metalloproteases and require metal ions like zinc for their catalytic activity .

How are aminopeptidases distributed across cellular compartments and organisms?

Aminopeptidases demonstrate ubiquitous distribution across living organisms, being found in prokaryotes and eukaryotes alike. Within cellular architecture, they are present in multiple compartments including the cytoplasm, various subcellular organelles, and as membrane components .

The distribution of specific aminopeptidases varies significantly between tissues. For example, research has shown that aminopeptidase B and aminopeptidase N are particularly abundant in the small intestine (duodenum, jejunum, and ileum) of rats, with specific activity levels three to fivefold higher than in other gastrointestinal organs . Immunohistochemical studies have revealed that aminopeptidase M is primarily concentrated at the luminal surface of the rat small intestine . These distribution patterns reflect the specialized functions aminopeptidases perform in different tissues.

What are the primary physiological roles of aminopeptidases in cellular processes?

Aminopeptidases play critical roles in fundamental cellular processes across all living organisms, including:

  • Protein maturation and activation: By processing N-terminal regions of precursor proteins

  • Protein degradation: Contributing to intracellular protein turnover and maintenance of free amino acid pools

  • Maintenance of genome stability: The enzyme aminopeptidase-P (APP1) has been shown to prevent DNA damage accumulation during DNA replication, protecting genome integrity during cellular proliferation

  • Regulation of growth and development: In plants, studies with Arabidopsis LAP2 indicate key roles in controlling vegetative growth

  • Stress response mechanisms: Plant aminopeptidases like LAP2 influence stress sensitivity and adaptation

  • Amino acid metabolism: LAP2 has been demonstrated to control intracellular amino acid turnover, affecting downstream metabolites like γ-aminobutyric acid

Recent research has expanded our understanding of aminopeptidase functions beyond traditional protein processing roles to include specialized functions in DNA replication, immune system regulation, and stress response pathways .

What experimental approaches are most effective for evaluating aminopeptidase substrate specificity?

Determining substrate specificity is fundamental to understanding aminopeptidase function. Several complementary methodologies have proven effective:

  • Solid-phase chemistry with fluorogenic reporters: A particularly effective approach involves using 7-amino-4-carbamoylmethylcoumarin (ACC) as a fluorescent reporter group. This allows for the synthesis of libraries containing diverse amino acids to systematically probe interactions within the S1 pocket of aminopeptidases . For example, researchers have synthesized a library of 61 natural and unnatural amino acid substrates to comprehensively evaluate the substrate preferences of aminopeptidase N (CD13) .

  • Mass spectrometry-based peptide library assays: This unbiased approach enables researchers to determine extended substrate preferences (P1-P4') of aminopeptidases by analyzing their action on diverse peptide libraries. This methodology has helped identify candidate peptide substrates for rational inhibitor design .

  • X-ray crystallography: Structural studies have proven invaluable for understanding the physical basis of substrate specificity. Crystal structures of aminopeptidases complexed with different amino acids in the P1 position provide a structural framework for interpreting biochemical data and guide inhibitor design .

  • Kinetic parameter analysis: Determination of enzymatic parameters (Km, kcat, Vmax) for different substrates helps quantify relative preferences and can inform structure-activity relationships .

These complementary approaches allow researchers to construct detailed interaction maps of aminopeptidase binding pockets and develop specific inhibitors without requiring extensive inhibitor library synthesis .

How can researchers effectively design and analyze aminopeptidase inhibition studies?

Designing rigorous aminopeptidase inhibition studies requires careful consideration of multiple factors:

  • Selection of appropriate substrate concentrations: Substrates should be used at concentrations below their Km values to ensure sensitivity to competitive inhibitors.

  • Incorporation of structure-guided approaches: Crystal structures of aminopeptidases, such as those from N. meningitidis, reveal how inhibitors like bestatin bind in the active site . These structures highlight key residues (like M256 and Y372) that undergo conformational changes to accommodate inhibitors .

  • Analysis of species-specific differences: Researchers should test inhibitors against aminopeptidase orthologs from different species (e.g., human, rat, pig) as substrate preferences can vary despite high sequence conservation . This allows identification of critical residues that determine inhibitor selectivity.

  • Integration of substrate specificity data: A notable finding is that for aminopeptidases, the relationship between substrate kinetic parameters and inhibitor potency differs from the patterns observed with other proteases like serine and cysteine proteases . Therefore, substrate preference data should inform but not solely dictate inhibitor design.

  • Validation across multiple aminopeptidase family members: Cross-screening against related aminopeptidases helps establish inhibitor selectivity profiles.

Researchers should also consider that aminopeptidases like ERAP1 and ERAP2 can form functional heterodimers with enhanced peptide-trimming efficiency, which may affect inhibition studies targeting individual enzymes .

What are the key considerations for experimental design in proteomics studies involving aminopeptidases?

Proteomics approaches for studying aminopeptidases require careful experimental design to address several challenges:

  • Sample preparation: Preservation of enzyme activity during extraction is crucial, especially for membrane-bound aminopeptidases like aminopeptidase N.

  • Data analysis challenges: As highlighted in proteomics studies, peptide identification involves matching experimental spectra to theoretical peptide fragments, but these matches can be imperfect. Researchers must be aware that score distributions for true and false matches often overlap, creating a "gray area" where confidence in identifications is unclear7.

  • Selection of appropriate controls: Researchers should include specific aminopeptidase inhibitors in parallel experiments to confirm the specificity of observed activities.

  • Detection methods: Fluorimetric detection has proven effective for quantifying aminopeptidase activity in tissue samples, as demonstrated in studies of aminopeptidase B in rat gastrointestinal organs .

  • Database limitations: When analyzing proteomics data, researchers should consider that peptides of interest might not be included in databases, potentially leading to misidentifications of similar peptides7.

  • Statistical validation: Implementation of rigorous statistical approaches is essential to distinguish true peptide identifications from false positives, especially in the overlapping score region7.

A comprehensive experimental design should incorporate these considerations to generate reliable data on aminopeptidase activities, substrates, and interaction partners.

How does aminopeptidase P (APP1) contribute to genome stability during DNA replication?

Recent groundbreaking research has revealed an unexpected role for aminopeptidase P (APP1) in maintaining genome integrity. Studies conducted by researchers from the MRC London Institute of Medical Sciences, Leeds University, and the Francis Crick Institute have demonstrated that APP1 prevents DNA damage accumulation during DNA replication .

The experimental approach involved:

  • Comparative studies using C. elegans worms lacking APP1, which displayed reduced cell proliferation and extensive accumulation of DNA double-strand breaks (DSBs)

  • Analysis of DSB repair kinetics, revealing that most breaks were eventually repaired in APP1 mutants

  • Extension of findings to human cells, where removal of APP1 similarly induced DNA damage accumulation

These results suggest that APP1's primary function is preventing the onset of DNA damage rather than participating in repair mechanisms. The conservation of this protective function across evolutionary diverse organisms (from C. elegans to humans) highlights its fundamental importance .

This discovery represents a significant advance in understanding how cellular metabolism beyond direct DNA processing can influence genome stability. The researchers suggest that APP1's activity in preventing replication-related genome instability could have therapeutic potential, opening new avenues for cancer treatment approaches .

What is known about the structural determinants of aminopeptidase substrate specificity?

Structural studies have provided critical insights into the molecular basis of aminopeptidase substrate specificity:

  • Active site architecture: Crystal structures of aminopeptidases like those from N. meningitidis reveal that the active site is positioned at the intersection of multiple domains. It is flanked by a β-sheet edge (containing strand β20) on one side and an α-helix (α5) on the opposite side . These regions contain highly conserved residues across the M1 protease family.

  • Conserved structural motifs: The β5 strand contains the G257-X-M259-E260-N261 endopeptidase fingerprint motif, while the α5 helix carries the conserved Y377 residue . These elements create a specific architecture for substrate recognition.

  • Metal coordination: The zinc-binding site is essential for catalytic activity, with specific residues coordinating the metal ion and determining substrate positioning.

  • Extended substrate binding: Studies of aminopeptidase N (APN) substrate specificity have mapped the P1-P4' amino acid preferences, revealing how regions beyond the catalytic site influence substrate recognition and processing .

  • Species variations: Despite high sequence conservation, structural differences in the substrate binding pockets of aminopeptidases from different species contribute to variations in substrate preferences .

These structural features have enabled researchers to create detailed models of how peptides interact with aminopeptidases and have guided the rational design of selective inhibitors. For example, crystal structures of APN complexed with various amino acids in the P1 position provided the foundation for modeling extended peptide interactions and developing a selective peptide inhibitor for cancer therapy .

How do plant aminopeptidases like LAP2 regulate growth, senescence, and stress responses?

Research on the Arabidopsis aminopeptidase LAP2 has revealed complex regulatory roles in plant physiology:

  • Growth regulation: Loss of LAP2 function results in reduced vegetative growth, indicating its importance in normal development processes .

  • Senescence control: LAP2 mutants display accelerated leaf senescence, suggesting that this aminopeptidase helps maintain leaf longevity under normal conditions .

  • Stress response modulation: Plants lacking LAP2 show increased sensitivity to various environmental stresses, highlighting its role in stress adaptation mechanisms .

  • Amino acid homeostasis: Integrated transcriptomic and metabolomic analyses revealed that LAP2 controls intracellular amino acid turnover. Specifically:

    • LAP2 mutants maintain free leucine levels by upregulating key genes involved in leucine biosynthesis

    • This compensation affects glutamate flux

    • Consequently, γ-aminobutyric acid (GABA), a glutamate-derived metabolite, is diminished in LAP2 mutants

    • These alterations in nitrogen-rich compounds correlate with the morphological changes and stress sensitivity observed in the mutants

  • Tissue-specific expression: LAP2 shows high expression in leaf vascular tissue and the quiescent center region, suggesting specialized functions in these locations .

These findings establish LAP2 as an enzymatically active aminopeptidase with significant roles in plant growth regulation, senescence timing, stress response, and amino acid metabolism . The research demonstrates how a single aminopeptidase can influence multiple physiological processes through its effects on protein and amino acid turnover.

What are the major challenges in studying aminopeptidase interactions in complex biological systems?

Researchers face several significant challenges when investigating aminopeptidase activities in complex biological contexts:

  • Asymmetric distribution and function: Evidence suggests asymmetric interactions between aminopeptidases in different brain regions. Studies indicate that aminopeptidases from left and right cortico-limbic locations interact differently with plasma enzymes and physiological parameters like systolic blood pressure . These asymmetric patterns complicate experimental design and data interpretation.

  • Heterodimer formation: Some aminopeptidases form functional heterodimers with enhanced activity. For example, ERAP1 and ERAP2 can dimerize to significantly increase peptide-trimming efficiency . This means studying individual enzymes in isolation may not accurately reflect their physiological behavior.

  • Tissue-specific distribution: Aminopeptidases show variable distribution across tissues. For instance, aminopeptidase B and N show 3-5 fold higher specific activity in the small intestine compared to other gastrointestinal organs in rats . This heterogeneity necessitates tissue-specific analyses.

  • Substrate competition in vivo: Multiple aminopeptidases may compete for the same substrates in biological systems, making it difficult to attribute specific functions to individual enzymes.

  • Integration with other cellular processes: Recent findings linking aminopeptidase P to genome stability during DNA replication highlight unexpected connections between aminopeptidases and other cellular functions that may be overlooked in traditional studies.

Addressing these challenges requires integrated approaches combining tissue-specific analyses, consideration of enzyme heterogeneity, and careful experimental design to capture the complexity of aminopeptidase functions in vivo.

How can researchers differentiate between the functions of various aminopeptidase family members?

Distinguishing the specific roles of different aminopeptidases in biological systems requires a multifaceted approach:

  • Substrate profiling: Comprehensive substrate specificity profiling using libraries of natural and unnatural amino acids can reveal distinct preferences among aminopeptidase family members. This approach has been successful for characterizing the substrate specificity of human, pig, and rat orthologs of aminopeptidase N (CD13) .

  • Genetic deletion studies: Targeted knockout or knockdown of specific aminopeptidases can reveal their non-redundant functions. For example, studies with LAP2 mutants in Arabidopsis demonstrated its specific roles in growth, senescence, and stress response that were not compensated by other aminopeptidases .

  • Tissue-specific expression analysis: Determining the precise tissue distribution of different aminopeptidases can provide clues to their specialized functions. Immunohistochemical studies have shown distinct localization patterns, such as aminopeptidase M's concentration at the luminal surface of the rat small intestine .

  • Structural comparisons: Crystallographic studies of different aminopeptidases reveal structural differences that can explain distinct substrate preferences and functions. Analysis of conserved motifs and variable regions helps identify determinants of specificity .

  • Inhibitor selectivity studies: Development and testing of selective inhibitors against multiple aminopeptidase family members can help differentiate their activities in complex samples.

  • Integrated 'omics approaches: Combining transcriptomics and metabolomics analyses, as demonstrated in studies of LAP2 in Arabidopsis , can reveal downstream effects specific to individual aminopeptidases.

These complementary approaches enable researchers to build a comprehensive understanding of the non-redundant and overlapping functions within the aminopeptidase family.

What are promising future research directions in aminopeptidase research?

Several emerging areas present exciting opportunities for advancing aminopeptidase research:

  • Therapeutic development: The discovery that aminopeptidase P (APP1) prevents replication-related genome instability suggests potential therapeutic applications . Further research could explore whether APP1 inhibitors might sensitize cancer cells to DNA damaging agents.

  • Structure-based drug design: Continued structural studies of aminopeptidases will facilitate the rational design of selective inhibitors. The approach of combining substrate profiling with crystallographic data has already yielded effective peptide inhibitors against APN-expressing cancer models .

  • Systems biology integration: Expanding our understanding of how aminopeptidases function within broader metabolic and signaling networks will reveal new regulatory connections. The work on LAP2 in Arabidopsis demonstrating links to amino acid turnover exemplifies this approach .

  • Heterodimer functionality: Further investigation of functional heterodimers like ERAP1-ERAP2, which show enhanced peptide-trimming efficiency , may reveal new regulatory mechanisms and potential therapeutic targets.

  • Brain asymmetry studies: The emerging evidence of asymmetric interactions between aminopeptidases in different brain regions opens new avenues for understanding brain lateralization and its implications for neurological conditions.

  • Advanced proteomics approaches: Improvements in proteomics methodologies will enable more accurate identification of aminopeptidase substrates and interaction partners in complex biological samples, addressing current limitations in spectral matching and database coverage7.

  • Evolutionary conservation analysis: Comparative studies across species will continue to illuminate the essential functions of aminopeptidases that have been conserved throughout evolution, as demonstrated by the conserved role of APP1 in protecting genome integrity .

These research directions promise to expand our fundamental understanding of aminopeptidases while developing practical applications in medicine, agriculture, and biotechnology.

Product Science Overview

Structure and Properties

Aminopeptidase Aeromonas Recombinant is a 29 kDa protein that consists of 291 amino acid residues . It is typically expressed in Escherichia coli (E. coli) systems, which allows for efficient production and purification . The enzyme is highly purified, with a purity of ≥ 98% as determined by SDS-PAGE gel and HPLC analyses .

Function and Mechanism

This enzyme functions as an exopeptidase, meaning it cleaves amino acids from the N-terminus of peptide chains . It specifically recognizes a stop sign at -X-Pro and requires a free α-amino group in the L-configuration . This makes it particularly useful for removing redundant N-terminal methionine residues that are often added during the production of recombinant proteins .

Applications

Aminopeptidase Aeromonas Recombinant has several important applications in the field of biochemistry and molecular biology:

  1. Processing of Pharmaceutical Proteins: It is used in the processing of pharmaceutical proteins produced by genetic engineering .
  2. Physical and Structural Investigations: The enzyme is employed in studies involving the physical and structural properties of proteins .
  3. Sequence and Amino-Terminal Determinations: It aids in determining the sequence and amino-terminal of proteins .
Storage and Handling

The enzyme is typically supplied in a lyophilized form and should be stored at -20°C to maintain its stability and activity . It is shipped at ambient temperature and should be reconstituted according to the specific instructions provided with the product .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.